αEβ7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4355-4362

  Woodberry, Tonia ^a   Suscovich, Todd J ^a   Henry, Leah M ^a   August, Meredith ^a   Waring, Michael T ^a   Kaur, Amitinder ^b   Hess, Christoph ^c   Kutok, Jeffery L ^d   Aster, Jon C ^d   Wang, Frederick ^d   Scadden, David T ^a   Brander, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; UVOMORULIN;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TONSIL CELL; VIRUS REPLICATION;

EID: 25444456374     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4355     Document Type: Article

References (57)

1. Sitki-Green, D., M. Covington, and N. Raab-Traub. 2003. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J. Virol. 77: 1840-1847.
2. Walling, D. M., A. L. Brown, W. Etienne, W. A. Keitel, and P. D. Ling. 2003. Multiple Epstein-Barr virus infections in healthy individuals. J. Virol. 77: 6546-6550.
3. Frahm, N., B. T. Korber, C. M. Adams, J. J. Szinger, R. Draenert, M. M. Addo, M. E. Feeney, K. Yusim, K. Sango, N. V. Brown, et al. 2004. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol 78: 2187-2200.
4. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193: 169-180.
5. Woodberry, T., T. Suscovich, L. Henry, J. K. Davis, N. Frahm, B. Walker, D. T. Scadden, F. Z. Wang, and C. Brander. 2005. Differential targeting and shifts in the immunodominance of EBV specific CD8 and CD4 T cell responses from acute to persistent infection. J. Infect. Dis. 192: 622-629.
6. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195: 893-905.
7. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15: 405-431.
8. Kaufmann, D. E., P. M. Bailey, J. Sidney, B. Wagner, P. J. Norris, M. N. Johnston, L. A. Cosimi, M. M. Addo, M. Lichterfeld, M. Altfeld, et al. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78: 4463-4477.
9. Mowat, A. M., and J. L. Viney. 1997. The anatomical basis of intestinal immunity. Immunol. Rev. 156: 145-166.
10. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
11. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
12. Shacklett, B. L., T. J. Beadle, P. A. Pacheco, J. H. Grendell, P. A. Haslett, A. S. King, G. S. Ogg, P. M. Basuk, and D. F. Nixon. 2000. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 270: 317-327.
13. + T cells to gut-associated lymphoid tissue during chronic infection. J. Virol 77:5621-5631.
14. Shacklett, B. L., S. Cu-Uvin, T. J. Beadle, C. A. Pace, N. M. Fast, S. M. Donahue, A. M. Caliendo, T. P. Flanigan, C. C. Carpenter, and D. F. Nixon. 2000. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 14: 1911-195.
15. + T cells from blood and tonsils during primary infection. Blood 103: 162-167.
16. + T cells. J. Immunol. 168: 4184-4191.
17. Appay, V., P. Hansasuta, J. Sutton, R. D. Schrier, J. K. Wong, M. Furtado, D. V. Havlir, S. M. Wolinsky, A. J. McMichael, D. D. Richman, et al. 2002. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS 16: 161-170.
18. Streeter, P. R., E. L. Berg, B. T. Rouse, R. F. Bargatze, and E. C. Butcher. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331: 41-46.
19. Mora, A. L., and J. P. Tam. 1998. Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations. J. Immunol. 161: 3616-3623.
20. + T lymphocytes by attenuated simian immunodeficiency virus. J. Virol. 74: 8762-8766.
21. Cerf-Bensussan, N., A. Jarry, N. Brousse, B. Lisowska-Grospierre, D. Guy-Grand, and C. Griscelli. 1987. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol. 17: 1279-1285.
22. 7 integrin. Nature 372: 190-193.
23. Berg, E. L., M. K. Robinson, R. A. Warnock, and E. C. Butcher. 1991. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J. Cell Biol. 114: 343-349.
24. + T cells in human livers; its association with extrathymic T cells. J. Hepatol. 39: 918-924.
25. 7, LEEP-CAM and chemokines. Curr. Opin. Cell Biol. 12: 563-568.
26. 7 adhesion to epithelial (E)-cadherin. J. Exp. Med. 191: 1555-1567.
27. Schieferdecker, H. L., R. Ullrich, A. N. Weiss-Breckwoldt, R. Schwarting, H. Stein, E. O. Riecken, and M. Zeitz. 1990. The HML-1 antigen of intestinal lymphocytes is an activation antigen. J. Immunol. 144: 2541-2549.
28. +). Thorax 58: 23-29.
29. 1 integrin expression. Am. J. Respir. Cell Mol. Biol. 10: 237-244.
30. Bernstein, J. M., R. Scheeren, E. Schoenfeld, and B. Albini. 1988. The distribution of immunocompetent cells in the compartments of the palatine tonsils in bacterial and viral infections of the upper respiratory tract. Acta Otolaryngol. Suppl. 454: 153-162.
31. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence- specific primers (PCR-SSP). Tissue Antigens 46: 355-367.
32. Bihl, F. K., E. Loggi, J. V. Chisholm, H. S. Hewitt, L. M. Henry, C. Linde, T. J. Suscovich, J. Wong, N. Frahm, P. Andreone, and C. Brander. 2005. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion and "RecycleSpot." J. Translational Med. 3: 20-39.
33. Frahm, N., P. Goulder, and C. Brander. 2002. Total assessment of HIV specific CTL responses: epitope clustering, processing preferences and the impact of HIV sequence heterogeneity. In HIV Molecular Immunology Database. C. B. B. Korber, B. Walker, R. Koup, J. Moore, B. Haynes, and G. Meyers, eds. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM.
34. Hess, C., T. K. Means, P. Autissier, T. Woodberry, M. Altfeld, M. M. Addo, N. Frahm, C. Brander, B. D. Walker, and A. D. Luster. 2004. IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 104: 3463-3471.
35. Goulder, P., Y. Tang, C. Brander, M. Betts, M. Altfeld, K. Annamalai, A. Trocha, S. He, E. Rosenberg, G. Ogg, et al. 2000. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J. Exp. Med. 192: 1819-1832.
36. Goulder, P. J., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, et al. 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193: 181-194.
37. Frahm, N., P. Goulder, and C. Brander. 2003. Broad HIV-1 specific CTL responses reveal extensive HLA class I binding promiscuity of HIV-derived, optimally defined CTL epitopes. In HIV Molecular Immunology Database. C. B. B. Korber, B. Walker, R. Koup, J. Moore, B. Haynes, and G. Meyers, eds. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM.
38. Sallusto, F., E. Kremmer, B. Palermo, A. Hoy, P. Ponath, S. Qin, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29: 2037-2045.
39. Campbell, D., G. F. Debes, B. Johnston, E. Wilson, and E. C. Butcher. 2003. Targeting T cell responses by selective chemokine receptor expression. Semin. Immunol. 15: 277-286.
40. + T cells with an effector phenotype and control of viral replication. Lancet 363: 863-866.
41. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111.
42. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
43. E: no more rejection? J. Exp. Med. 196: 873-875.
44. McFarland, R. D., D. C. Douek, R. A. Koup, and L. J. Picker. 2000. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 97: 4215-4220.
45. Delgado, J., J. G. Bustos, M. C. Jimenez, E. Quevedo, and F. Hernandez-Navarro. 2002. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders? Leuk. Lymphoma 43: 2331-2334.
46. + T cells responding to renal allografts. J. Immunol. 172: 214-221.
47. + T cells. J. Exp. Med. 196: 877-886.
48. + thymocytes lead to enhanced thymocyte cell proliferation. J. Cell Sci. 115: 4505-4515.
49. Kaul, R., P. Thottingal, J. Kimani, P. Kiama, C. W. Waigwa, J. J. Bwayo, F. A. Plummer, and S. L. Rowland-Jones. 2003. Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women. AIDS 17: 1139-1144.
50. 7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interaction. J. Immunol. 166: 3506-3514.
51. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9: 395-404.
52. Babcock, G. J., D. Hochberg, and A. D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497-506.
53. Shieh, C. C., B. K. Sadasivan, G. J. Russell, M. P. Schon, C. M. Parker, and M. B. Brenner. 1999. Lymphocyte adhesion to epithelia and endothelia mediated by the lymphocyte endothelial-epithelial cell adhesion molecule glycoprotein. J. Immunol. 163: 1592-1601.
54. Bernstein, D. C., and G. M. Shearer. 1988. Suppression of human cytotoxic T lymphocyte responses by adherent peripheral blood leukocytes. Ann. NY Acad. Sci. 532: 207-213.
55. + T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J. Immunol. 163: 2226-2235.
56. + Treg and control of Leishmania major infection. J. Immunol. 174: 5444-5455.
57. Rao, P. E., A. L. Petrone, and P. D. Ponath. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174: 1446-1455.